Fluconazole-induced Stevens-Johnson syndrome at Libreville University Hospital - Gabon: A case report
- 14 March 2025
- journal article
- Published by SAGE Publications in International Journal of Risk & Safety in Medicine
Abstract
Background: Stevens-Johnson syndrome (SJS), a rare and severe toxic epidermal necrolysis, is reported here for the first time at the University Hospital Center of Libreville (CHUL), suspected to be related to fluconazole administration. Objective: To inform clinicians about the risks associated with fluconazole in immunocompromised patients and the related healthcare expenses. Case presentation: The patient is a 39-year-old immunocompromised woman who received a single dose 400 mg of fluconazole. Two weeks later, she developed a rash affecting approximately 10 % of her body surface, confirmed as SJS. During clinical examinations, no signs of infection, such as fever, dizziness, or chills, were present, suggesting a drug-induced SJS reaction. Results: Causality assessment assigned an intrinsic score of I6 and extrinsic score of B2 according to the French method, and a probable temporal relationship was confirmed using the world Health Organization (WHO) method. The ALDEN scale identified fluconazole as the probable cause (score = 4). No additional risk factors were identified (SCORTEN = 0, predicted mortality: 3.2 %). Economically, the total direct medical cost of hospitalization amounted to 605,700 CFA francs, or 923.38 €. Conclusion: Immunocompromised HIV-positive patients treated with 400 mg of fluconazole are likely to develop SJS and incur costs.Keywords
This publication has 10 references indexed in Scilit:
- Case report on Fluconazole Induced stevens -Johnson SyndromeResearch Journal of Pharmacy and Technology, 2019
- Réactualisation de la méthode française d’imputabilité des effets indésirables des médicamentsTherapies, 2011
- ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control AnalysisClinical Pharmacology & Therapeutics, 2010
- Fluconazole induced toxic epidermal necrolysis: a case reportCases Journal, 2009
- Toxic epidermal necrolysisJournal of the American Academy of Dermatology, 2007
- A marker for Stevens–Johnson syndromeNature, 2004
- Itraconazole and Fluconazole and Certain Rare, Serious Adverse EventsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- SCORTEN: A Severity-of-Illness Score for Toxic Epidermal NecrolysisJournal of Investigative Dermatology, 2000
- Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptorsClinical and Experimental Immunology, 2000
- Stevens-Johnson syndrome after fluconazoleThe Lancet, 1991